STAT News

STAT News
Name	STAT News
Type	Online publication
Founded	2015
Founder	John W. Henry
Headquarters	Boston, Massachusetts
Language	English

STAT News is an American health and life sciences news outlet founded in 2015. It covers biotechnology, pharmaceuticals, clinical trials, public health, and biomedical research with a focus on investigative reporting and analysis. The outlet operates digitally and has reported on topics intersecting with policy, industry, and academia.

History

STAT was launched in 2015 with backing from John W. Henry and an editorial team drawn from outlets including The Boston Globe, The New York Times, Nature (journal), Science (journal), and Reuters. Early staff included veterans from Bloomberg News, The Wall Street Journal, and The Washington Post, and the site quickly pursued long-form investigative work alongside beat reporting on Food and Drug Administration, National Institutes of Health, and Centers for Disease Control and Prevention developments. Its formation paralleled expansions in digital specialist outlets such as ProPublica, Vox, and Quartz (publication), and it competed for attention with legacy titles like The New Yorker and Time (magazine). Coverage in its first years intersected with major events such as the Zika virus outbreak and debates over Affordable Care Act implementation.

Ownership and Funding

The publication was initially financed by John W. Henry, principal owner of the Boston Red Sox and The Boston Globe parent companies. Its funding model combined private ownership, advertising, sponsored content partnerships with organizations like Pharmaceutical Research and Manufacturers of America and other industry stakeholders, and subscription features similar to membership models used by The New York Times Company and The Washington Post Company. The outlet's financial backers and partnerships occasionally drew comparisons to nonprofit-supported journalism organizations such as Kaiser Family Foundation and Robert Wood Johnson Foundation, and to venture-funded media ventures like Vox Media.

Coverage and Editorial Focus

The site's beats include biotechnology, pharmaceuticals, clinical trials, health policy, and biomedical research, frequently reporting on entities such as Moderna, Pfizer, Johnson & Johnson, AstraZeneca, Gilead Sciences, Novartis, Roche, and Merck & Co.. It reports on regulatory activity at agencies including the Food and Drug Administration, Centers for Disease Control and Prevention, National Institutes of Health, and European Medicines Agency. Editorially, it has focused on investigatory series into conflicts of interest at institutions like Harvard University, Massachusetts General Hospital, and Johns Hopkins University, and science-policy intersections involving figures tied to White House administrations and congressional committees such as the United States Senate Committee on Health, Education, Labor and Pensions. The outlet has run explanatory pieces on research published in journals like Nature (journal), Science (journal), and The Lancet.

Notable Reporting and Impact

Reportage has included investigative work that influenced public discourse around clinical-trial practices at contract research organizations and pharmaceutical companies including Theranos, which intersected with reporting by The Wall Street Journal and legal actions involving figures linked to Elizabeth Holmes. Coverage of pandemic-era developments paralleled reporting by The New York Times, The Washington Post, and Bloomberg News on vaccine development by Moderna and Pfizer–BioNTech and regulatory decisions at the Food and Drug Administration. Investigations have prompted responses from academic institutions such as Harvard Medical School and hospitals including Massachusetts General Hospital and been cited in hearings before congressional panels like the United States House Committee on Energy and Commerce. The outlet's pieces have been discussed on programs from networks including NPR, CNN, and MSNBC and referenced in audits by organizations akin to Government Accountability Office.

Organization and Leadership

Editorial leadership has included senior journalists with backgrounds at The Boston Globe, The New York Times, Stat News (forbidden), and Reuters; its executive structure mirrors that of digital newsrooms such as BuzzFeed News and Vox. The newsroom is based in Boston, Massachusetts with correspondents reporting from hubs including Washington, D.C., New York City, and biotechnology centers like Cambridge, Massachusetts and San Francisco, California. The organization has engaged contributors from academic institutions such as Harvard University, Johns Hopkins University, Stanford University, and Massachusetts Institute of Technology, and collaborates on data projects with groups similar to ProPublica and newsrooms like The Guardian.

Reception and Criticism

The outlet has been praised by entities including journalism awards committees that recognize investigative work similar to the Pulitzer Prize and media critics at Columbia Journalism Review for deep coverage of scientific and medical issues. Critics and some industry figures have raised concerns about perceived ties to funders and potential conflicts of interest, echoing broader debates involving organizations like Kaiser Family Foundation and coverage practices at outlets such as The New York Times. Reporting has occasionally drawn legal scrutiny from corporations and high-profile defendants featured in investigations, paralleling disputes seen in litigation involving Theranos and reporting by The Wall Street Journal. Academic commentators from Harvard T.H. Chan School of Public Health and think tanks like Brookings Institution have both cited and critiqued its analyses on health policy topics.

Category:American news websites